| Asset Summary |
 |
|
|
|
|
|
|
|
|
maxcyte.com Multimedia Content
|
|
|
|
Related Images on Weblo.com
|
|
|
 |
maxcyte.com News |
Read All News
|
Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan.
... YOKOHAMA, Japan, Aug. 27 /PRNewswire/ -- MaxCyte, Inc. and Medinet Co., Ltd. announced ... development and supply agreement to use MaxCyte's proprietary cell loading system to support ... in Japan. Under terms of the agreement, MaxCyte will pr... |
TheraMed Becomes MaxCyte(TM).
ROCKVILLE, Md., Oct. 4 /PRNewswire/ -- MaxCyte today announced the launch of its new name and logo. MaxCyte, a privately held biotechnology company... |
MaxCyte to Be Featured at the Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference.
GAITHERSBURG, Md., April 21 /PRNewswire/ -- MaxCyte, Inc., a clinical stage therapeutic company and pioneer ... development and biotherapeutic manu... |
|
|
|
|
|
maxcyte.com Description
|
|
MaxCyte
MaxCyte
domain name is still available in Weblo virtual world;
you can register it right now to profile yourself and send virtual traffic to your website.
Please scroll down to find where available, pictures, news and related videos.
Once you claim you can add or edit any information.
MaxCyte:
Develops targeted drugs and non-viral gene delivery systems. Also, specialized in enhanced oxygen to cells treatments.  idx_4c.jpg  idx_3c.jpg
|
|
|
|
Virtual World, Real Profit!
| 
